Climb Bio, Inc. (CLYM)
7.15
-0.23
(-3.12%)
USD |
NASDAQ |
Feb 27, 16:00
7.17
+0.02
(+0.28%)
Pre-Market: 20:00
Climb Bio Free Cash Flow : -44.43M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.194B |
| Fortress Biotech, Inc. | -30.14M |
| Oramed Pharmaceuticals, Inc. | -11.03M |
| Lyell Immunopharma, Inc. | -165.54M |
| PepGen Inc. | -85.76M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.14M |
| Cash from Investing (Quarterly) | 15.26M |
| Free Cash Flow Per Share (Quarterly) | -0.1801 |
| Free Cash Flow to Equity (Quarterly) | -12.19M |
| Free Cash Flow to Firm (Quarterly) | -12.25M |
| Free Cash Flow Yield | -9.20% |